nodes	percent_of_prediction	percent_of_DWPC	metapath
Labetalol—Hyperthyroidism—Sorafenib—liver cancer	0.0547	0.0567	CcSEcCtD
Labetalol—Alopecia reversible—Epirubicin—liver cancer	0.0352	0.0365	CcSEcCtD
Labetalol—Respiratory distress—Sorafenib—liver cancer	0.0341	0.0353	CcSEcCtD
Labetalol—Alopecia reversible—Doxorubicin—liver cancer	0.0326	0.0338	CcSEcCtD
Labetalol—Oropharyngeal discomfort—Sorafenib—liver cancer	0.0297	0.0308	CcSEcCtD
Labetalol—Cardiac failure—Sorafenib—liver cancer	0.0161	0.0167	CcSEcCtD
Labetalol—Mood swings—Sorafenib—liver cancer	0.0149	0.0154	CcSEcCtD
Labetalol—Abdominal pain upper—Sorafenib—liver cancer	0.0143	0.0149	CcSEcCtD
Labetalol—Benazepril—MTHFR—liver cancer	0.0136	0.388	CrCbGaD
Labetalol—Erectile dysfunction—Sorafenib—liver cancer	0.0125	0.013	CcSEcCtD
Labetalol—Jaundice—Sorafenib—liver cancer	0.0118	0.0122	CcSEcCtD
Labetalol—Epistaxis—Sorafenib—liver cancer	0.0114	0.0118	CcSEcCtD
Labetalol—Ventricular arrhythmia—Epirubicin—liver cancer	0.0108	0.0112	CcSEcCtD
Labetalol—Flushing—Sorafenib—liver cancer	0.0101	0.0104	CcSEcCtD
Labetalol—Ventricular arrhythmia—Doxorubicin—liver cancer	0.00999	0.0104	CcSEcCtD
Labetalol—Alopecia—Sorafenib—liver cancer	0.0096	0.00995	CcSEcCtD
Labetalol—Mental disorder—Sorafenib—liver cancer	0.00952	0.00986	CcSEcCtD
Labetalol—Erythema—Sorafenib—liver cancer	0.00946	0.0098	CcSEcCtD
Labetalol—Jaundice cholestatic—Epirubicin—liver cancer	0.0091	0.00943	CcSEcCtD
Labetalol—Muscle spasms—Sorafenib—liver cancer	0.00909	0.00942	CcSEcCtD
Labetalol—Angioedema—Sorafenib—liver cancer	0.00864	0.00895	CcSEcCtD
Labetalol—Syncope—Sorafenib—liver cancer	0.00848	0.00879	CcSEcCtD
Labetalol—Jaundice cholestatic—Doxorubicin—liver cancer	0.00842	0.00872	CcSEcCtD
Labetalol—Loss of consciousness—Sorafenib—liver cancer	0.00831	0.00861	CcSEcCtD
Labetalol—Atrioventricular block—Epirubicin—liver cancer	0.00824	0.00854	CcSEcCtD
Labetalol—Hypertension—Sorafenib—liver cancer	0.00816	0.00846	CcSEcCtD
Labetalol—Anaphylactic shock—Sorafenib—liver cancer	0.00772	0.008	CcSEcCtD
Labetalol—Atrioventricular block—Doxorubicin—liver cancer	0.00763	0.0079	CcSEcCtD
Labetalol—Shock—Sorafenib—liver cancer	0.00759	0.00787	CcSEcCtD
Labetalol—Blood urea increased—Epirubicin—liver cancer	0.00755	0.00782	CcSEcCtD
Labetalol—Dry eye—Epirubicin—liver cancer	0.00738	0.00765	CcSEcCtD
Labetalol—Blood urea increased—Doxorubicin—liver cancer	0.00698	0.00724	CcSEcCtD
Labetalol—Mirabegron—ALB—liver cancer	0.00689	0.197	CrCbGaD
Labetalol—Dyspnoea—Sorafenib—liver cancer	0.00688	0.00713	CcSEcCtD
Labetalol—Dry eye—Doxorubicin—liver cancer	0.00683	0.00708	CcSEcCtD
Labetalol—Dyspepsia—Sorafenib—liver cancer	0.00679	0.00704	CcSEcCtD
Labetalol—Fatigue—Sorafenib—liver cancer	0.00665	0.0069	CcSEcCtD
Labetalol—Pain—Sorafenib—liver cancer	0.0066	0.00684	CcSEcCtD
Labetalol—Constipation—Sorafenib—liver cancer	0.0066	0.00684	CcSEcCtD
Labetalol—Gastrointestinal pain—Sorafenib—liver cancer	0.00631	0.00654	CcSEcCtD
Labetalol—Urticaria—Sorafenib—liver cancer	0.00613	0.00635	CcSEcCtD
Labetalol—Body temperature increased—Sorafenib—liver cancer	0.0061	0.00632	CcSEcCtD
Labetalol—Abdominal pain—Sorafenib—liver cancer	0.0061	0.00632	CcSEcCtD
Labetalol—Anaphylactoid reaction—Epirubicin—liver cancer	0.006	0.00621	CcSEcCtD
Labetalol—Cardiac failure—Epirubicin—liver cancer	0.00595	0.00616	CcSEcCtD
Labetalol—Hypoglycaemia—Epirubicin—liver cancer	0.00595	0.00616	CcSEcCtD
Labetalol—Lethargy—Epirubicin—liver cancer	0.00592	0.00614	CcSEcCtD
Labetalol—Affect lability—Epirubicin—liver cancer	0.00571	0.00592	CcSEcCtD
Labetalol—Hypersensitivity—Sorafenib—liver cancer	0.00569	0.00589	CcSEcCtD
Labetalol—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00555	0.00575	CcSEcCtD
Labetalol—Asthenia—Sorafenib—liver cancer	0.00554	0.00574	CcSEcCtD
Labetalol—Hypoglycaemia—Doxorubicin—liver cancer	0.0055	0.0057	CcSEcCtD
Labetalol—Cardiac failure—Doxorubicin—liver cancer	0.0055	0.0057	CcSEcCtD
Labetalol—Mood swings—Epirubicin—liver cancer	0.0055	0.0057	CcSEcCtD
Labetalol—Lethargy—Doxorubicin—liver cancer	0.00548	0.00568	CcSEcCtD
Labetalol—Pruritus—Sorafenib—liver cancer	0.00546	0.00566	CcSEcCtD
Labetalol—Liver function test abnormal—Epirubicin—liver cancer	0.00536	0.00555	CcSEcCtD
Labetalol—Isoprenaline—CYP1A1—liver cancer	0.00532	0.152	CrCbGaD
Labetalol—Orthostatic hypotension—Epirubicin—liver cancer	0.0053	0.00549	CcSEcCtD
Labetalol—Abdominal pain upper—Epirubicin—liver cancer	0.0053	0.00549	CcSEcCtD
Labetalol—Affect lability—Doxorubicin—liver cancer	0.00528	0.00548	CcSEcCtD
Labetalol—Diarrhoea—Sorafenib—liver cancer	0.00528	0.00547	CcSEcCtD
Labetalol—Dizziness—Sorafenib—liver cancer	0.0051	0.00529	CcSEcCtD
Labetalol—Mood swings—Doxorubicin—liver cancer	0.00509	0.00527	CcSEcCtD
Labetalol—Liver function test abnormal—Doxorubicin—liver cancer	0.00496	0.00514	CcSEcCtD
Labetalol—Vomiting—Sorafenib—liver cancer	0.00491	0.00509	CcSEcCtD
Labetalol—Orthostatic hypotension—Doxorubicin—liver cancer	0.0049	0.00508	CcSEcCtD
Labetalol—Abdominal pain upper—Doxorubicin—liver cancer	0.0049	0.00508	CcSEcCtD
Labetalol—Angina pectoris—Epirubicin—liver cancer	0.00489	0.00506	CcSEcCtD
Labetalol—Rash—Sorafenib—liver cancer	0.00487	0.00504	CcSEcCtD
Labetalol—Dermatitis—Sorafenib—liver cancer	0.00486	0.00504	CcSEcCtD
Labetalol—Headache—Sorafenib—liver cancer	0.00483	0.00501	CcSEcCtD
Labetalol—Dysuria—Epirubicin—liver cancer	0.00469	0.00486	CcSEcCtD
Labetalol—Nausea—Sorafenib—liver cancer	0.00458	0.00475	CcSEcCtD
Labetalol—Angina pectoris—Doxorubicin—liver cancer	0.00452	0.00468	CcSEcCtD
Labetalol—Drowsiness—Epirubicin—liver cancer	0.00447	0.00463	CcSEcCtD
Labetalol—Jaundice—Epirubicin—liver cancer	0.00436	0.00452	CcSEcCtD
Labetalol—Dysuria—Doxorubicin—liver cancer	0.00434	0.0045	CcSEcCtD
Labetalol—Sweating—Epirubicin—liver cancer	0.00429	0.00444	CcSEcCtD
Labetalol—Epistaxis—Epirubicin—liver cancer	0.00422	0.00437	CcSEcCtD
Labetalol—Agranulocytosis—Epirubicin—liver cancer	0.00417	0.00432	CcSEcCtD
Labetalol—Drowsiness—Doxorubicin—liver cancer	0.00414	0.00429	CcSEcCtD
Labetalol—Fenoprofen—ALB—liver cancer	0.00412	0.117	CrCbGaD
Labetalol—Bradycardia—Epirubicin—liver cancer	0.00409	0.00424	CcSEcCtD
Labetalol—Jaundice—Doxorubicin—liver cancer	0.00403	0.00418	CcSEcCtD
Labetalol—Hepatitis—Epirubicin—liver cancer	0.00401	0.00416	CcSEcCtD
Labetalol—Hypoaesthesia—Epirubicin—liver cancer	0.00399	0.00414	CcSEcCtD
Labetalol—Sweating—Doxorubicin—liver cancer	0.00397	0.00411	CcSEcCtD
Labetalol—Oedema peripheral—Epirubicin—liver cancer	0.00395	0.0041	CcSEcCtD
Labetalol—Epistaxis—Doxorubicin—liver cancer	0.0039	0.00404	CcSEcCtD
Labetalol—Visual impairment—Epirubicin—liver cancer	0.00387	0.00401	CcSEcCtD
Labetalol—Agranulocytosis—Doxorubicin—liver cancer	0.00386	0.004	CcSEcCtD
Labetalol—Bradycardia—Doxorubicin—liver cancer	0.00378	0.00392	CcSEcCtD
Labetalol—Flushing—Epirubicin—liver cancer	0.00373	0.00386	CcSEcCtD
Labetalol—Hepatitis—Doxorubicin—liver cancer	0.00371	0.00385	CcSEcCtD
Labetalol—Hypoaesthesia—Doxorubicin—liver cancer	0.0037	0.00383	CcSEcCtD
Labetalol—Oedema peripheral—Doxorubicin—liver cancer	0.00366	0.00379	CcSEcCtD
Labetalol—Visual impairment—Doxorubicin—liver cancer	0.00358	0.00371	CcSEcCtD
Labetalol—Alopecia—Epirubicin—liver cancer	0.00355	0.00368	CcSEcCtD
Labetalol—Mental disorder—Epirubicin—liver cancer	0.00352	0.00364	CcSEcCtD
Labetalol—Erythema—Epirubicin—liver cancer	0.00349	0.00362	CcSEcCtD
Labetalol—Flushing—Doxorubicin—liver cancer	0.00345	0.00357	CcSEcCtD
Labetalol—Muscle spasms—Epirubicin—liver cancer	0.00336	0.00348	CcSEcCtD
Labetalol—Vision blurred—Epirubicin—liver cancer	0.00329	0.00341	CcSEcCtD
Labetalol—Alopecia—Doxorubicin—liver cancer	0.00328	0.0034	CcSEcCtD
Labetalol—Mental disorder—Doxorubicin—liver cancer	0.00325	0.00337	CcSEcCtD
Labetalol—Ill-defined disorder—Epirubicin—liver cancer	0.00324	0.00336	CcSEcCtD
Labetalol—Erythema—Doxorubicin—liver cancer	0.00323	0.00335	CcSEcCtD
Labetalol—Malaise—Epirubicin—liver cancer	0.00315	0.00327	CcSEcCtD
Labetalol—Vertigo—Epirubicin—liver cancer	0.00314	0.00325	CcSEcCtD
Labetalol—Syncope—Epirubicin—liver cancer	0.00313	0.00325	CcSEcCtD
Labetalol—Muscle spasms—Doxorubicin—liver cancer	0.00311	0.00322	CcSEcCtD
Labetalol—Palpitations—Epirubicin—liver cancer	0.00309	0.0032	CcSEcCtD
Labetalol—Loss of consciousness—Epirubicin—liver cancer	0.00307	0.00318	CcSEcCtD
Labetalol—Vision blurred—Doxorubicin—liver cancer	0.00305	0.00316	CcSEcCtD
Labetalol—Hypertension—Epirubicin—liver cancer	0.00302	0.00313	CcSEcCtD
Labetalol—Ill-defined disorder—Doxorubicin—liver cancer	0.003	0.00311	CcSEcCtD
Labetalol—Discomfort—Epirubicin—liver cancer	0.00294	0.00305	CcSEcCtD
Labetalol—Malaise—Doxorubicin—liver cancer	0.00292	0.00302	CcSEcCtD
Labetalol—Vertigo—Doxorubicin—liver cancer	0.00291	0.00301	CcSEcCtD
Labetalol—Syncope—Doxorubicin—liver cancer	0.0029	0.00301	CcSEcCtD
Labetalol—Confusional state—Epirubicin—liver cancer	0.00288	0.00298	CcSEcCtD
Labetalol—Palpitations—Doxorubicin—liver cancer	0.00286	0.00296	CcSEcCtD
Labetalol—Oedema—Epirubicin—liver cancer	0.00285	0.00296	CcSEcCtD
Labetalol—Anaphylactic shock—Epirubicin—liver cancer	0.00285	0.00296	CcSEcCtD
Labetalol—Loss of consciousness—Doxorubicin—liver cancer	0.00284	0.00295	CcSEcCtD
Labetalol—Shock—Epirubicin—liver cancer	0.00281	0.00291	CcSEcCtD
Labetalol—Hypertension—Doxorubicin—liver cancer	0.00279	0.00289	CcSEcCtD
Labetalol—Hyperhidrosis—Epirubicin—liver cancer	0.00276	0.00286	CcSEcCtD
Labetalol—Discomfort—Doxorubicin—liver cancer	0.00272	0.00282	CcSEcCtD
Labetalol—Flurbiprofen—ALB—liver cancer	0.00269	0.0767	CrCbGaD
Labetalol—Hypotension—Epirubicin—liver cancer	0.00267	0.00276	CcSEcCtD
Labetalol—Confusional state—Doxorubicin—liver cancer	0.00266	0.00276	CcSEcCtD
Labetalol—Oedema—Doxorubicin—liver cancer	0.00264	0.00273	CcSEcCtD
Labetalol—Anaphylactic shock—Doxorubicin—liver cancer	0.00264	0.00273	CcSEcCtD
Labetalol—Shock—Doxorubicin—liver cancer	0.0026	0.00269	CcSEcCtD
Labetalol—Paraesthesia—Epirubicin—liver cancer	0.00256	0.00265	CcSEcCtD
Labetalol—Hyperhidrosis—Doxorubicin—liver cancer	0.00255	0.00264	CcSEcCtD
Labetalol—Dyspnoea—Epirubicin—liver cancer	0.00254	0.00264	CcSEcCtD
Labetalol—Somnolence—Epirubicin—liver cancer	0.00254	0.00263	CcSEcCtD
Labetalol—Dyspepsia—Epirubicin—liver cancer	0.00251	0.0026	CcSEcCtD
Labetalol—Hypotension—Doxorubicin—liver cancer	0.00247	0.00256	CcSEcCtD
Labetalol—Fatigue—Epirubicin—liver cancer	0.00246	0.00255	CcSEcCtD
Labetalol—Constipation—Epirubicin—liver cancer	0.00244	0.00253	CcSEcCtD
Labetalol—Pain—Epirubicin—liver cancer	0.00244	0.00253	CcSEcCtD
Labetalol—Ketoprofen—ALB—liver cancer	0.00243	0.0693	CrCbGaD
Labetalol—Paraesthesia—Doxorubicin—liver cancer	0.00237	0.00246	CcSEcCtD
Labetalol—Dyspnoea—Doxorubicin—liver cancer	0.00235	0.00244	CcSEcCtD
Labetalol—Feeling abnormal—Epirubicin—liver cancer	0.00235	0.00244	CcSEcCtD
Labetalol—Somnolence—Doxorubicin—liver cancer	0.00235	0.00243	CcSEcCtD
Labetalol—Gastrointestinal pain—Epirubicin—liver cancer	0.00233	0.00242	CcSEcCtD
Labetalol—Dyspepsia—Doxorubicin—liver cancer	0.00232	0.00241	CcSEcCtD
Labetalol—Fatigue—Doxorubicin—liver cancer	0.00228	0.00236	CcSEcCtD
Labetalol—Urticaria—Epirubicin—liver cancer	0.00227	0.00235	CcSEcCtD
Labetalol—Constipation—Doxorubicin—liver cancer	0.00226	0.00234	CcSEcCtD
Labetalol—Pain—Doxorubicin—liver cancer	0.00226	0.00234	CcSEcCtD
Labetalol—Abdominal pain—Epirubicin—liver cancer	0.00225	0.00234	CcSEcCtD
Labetalol—Body temperature increased—Epirubicin—liver cancer	0.00225	0.00234	CcSEcCtD
Labetalol—Feeling abnormal—Doxorubicin—liver cancer	0.00217	0.00225	CcSEcCtD
Labetalol—Gastrointestinal pain—Doxorubicin—liver cancer	0.00216	0.00224	CcSEcCtD
Labetalol—Hypersensitivity—Epirubicin—liver cancer	0.0021	0.00218	CcSEcCtD
Labetalol—Urticaria—Doxorubicin—liver cancer	0.0021	0.00217	CcSEcCtD
Labetalol—Abdominal pain—Doxorubicin—liver cancer	0.00209	0.00216	CcSEcCtD
Labetalol—Body temperature increased—Doxorubicin—liver cancer	0.00209	0.00216	CcSEcCtD
Labetalol—Asthenia—Epirubicin—liver cancer	0.00205	0.00212	CcSEcCtD
Labetalol—Pruritus—Epirubicin—liver cancer	0.00202	0.00209	CcSEcCtD
Labetalol—Diarrhoea—Epirubicin—liver cancer	0.00195	0.00202	CcSEcCtD
Labetalol—Hypersensitivity—Doxorubicin—liver cancer	0.00194	0.00201	CcSEcCtD
Labetalol—Asthenia—Doxorubicin—liver cancer	0.00189	0.00196	CcSEcCtD
Labetalol—Dizziness—Epirubicin—liver cancer	0.00189	0.00195	CcSEcCtD
Labetalol—Pruritus—Doxorubicin—liver cancer	0.00187	0.00193	CcSEcCtD
Labetalol—Vomiting—Epirubicin—liver cancer	0.00181	0.00188	CcSEcCtD
Labetalol—Diarrhoea—Doxorubicin—liver cancer	0.00181	0.00187	CcSEcCtD
Labetalol—Rash—Epirubicin—liver cancer	0.0018	0.00186	CcSEcCtD
Labetalol—Dermatitis—Epirubicin—liver cancer	0.0018	0.00186	CcSEcCtD
Labetalol—Headache—Epirubicin—liver cancer	0.00179	0.00185	CcSEcCtD
Labetalol—Dizziness—Doxorubicin—liver cancer	0.00175	0.00181	CcSEcCtD
Labetalol—Nausea—Epirubicin—liver cancer	0.00169	0.00176	CcSEcCtD
Labetalol—Vomiting—Doxorubicin—liver cancer	0.00168	0.00174	CcSEcCtD
Labetalol—Rash—Doxorubicin—liver cancer	0.00166	0.00172	CcSEcCtD
Labetalol—Dermatitis—Doxorubicin—liver cancer	0.00166	0.00172	CcSEcCtD
Labetalol—Headache—Doxorubicin—liver cancer	0.00165	0.00171	CcSEcCtD
Labetalol—Nausea—Doxorubicin—liver cancer	0.00157	0.00162	CcSEcCtD
